Randomized Trial of eOncoNote

NACompletedINTERVENTIONAL
Enrollment

181

Participants

Timeline

Start Date

February 5, 2018

Primary Completion Date

August 31, 2020

Study Completion Date

February 17, 2021

Conditions
Communication ResearchBreast CancerProstate CancerColorectal CancerLung CancerProgram, CommunicationRemote Consultation
Interventions
BEHAVIORAL

eOncoNote

"* Diagnosis phase: The patient's nurse navigator will initiate an eOncoNote to the patient's PCP, inviting them to send any questions related to the patient's diagnostic process. The nurse navigator will initiate case closure after the diagnostic process has been completed (case will be open up to 4 months).~* Treatment phase: The patient's medical or radiation oncologist will initiate an eOncoNote to the patient's PCP inviting them to ask questions related to the patient's cancer treatment and/or request information related to the patient's co-morbidities. The oncologist will initiate case closure after the treatment has been completed.~* Survivorship phase: The patient's registered nurse within the Wellness Beyond Cancer Program will send an eOncoNote invitation to the patient's PCP inviting them to ask any questions as the patient transitions back to their care. The nurse will initiate case closure after one year."

Trial Locations (1)

K1H 8L6

The Ottawa Hospital Research Institute, Ottawa

All Listed Sponsors
collaborator

Ontario Clinical Oncology Group (OCOG)

OTHER

collaborator

Ottawa Regional Cancer Centre

OTHER

lead

University of Toronto

OTHER

NCT03333785 - Randomized Trial of eOncoNote | Biotech Hunter | Biotech Hunter